Thoracic Neoplasms Flashcards

1
Q

Mediastinum

A

Anatomic space located between the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anterior mediastinum borders

A

Sternum to anterior aspect of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anterior mediastinum contents

A

Thymus
Internal mammary arteries
Lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MC etiologies of anterior mediastinal masses

A

Thymoma
Teratoma
Thyroid/parathyroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Middle mediastinal borders

A

Anterior aspect of the heart to the posterior aspect of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Contents of middle mediastinum

A

Heart
Great vessels
Trachea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MC etiologies of middle mediastinal masses

A

Granulomatous or metastatic lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Posterior mediastinum borders

A

Everything posterior to the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Contents of posterior mediastinum

A

Esophagus
Thoracic duct
Sympathetic chain
Spine
Descending thoracic aorta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MC etiologies of posterior mediastinal masses

A

Neurogenic tumors
Meningocele
Esophageal diverticula
Hiatal hernia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

50% of mediastinal masses are found ___

A

Incidentally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical presentation of mediastinal mass

A

Symptoms related to the structures that are compressed by the mass
Constitutional symptoms if malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effects of compression of the lungs, esophagus, vascular, heart and sympathetic chain

A

Lungs: hoarseness
Esophagus: dysphagia
Vascular: facial or extremity swelling
Heart: hypotension
Sympathetic chain: Horner’s syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Initial imaging of a mediastinal mass

A

CXR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

If the CXR is inconclusive, what is the follow-up imaging for mediastinal mass?

A

Chest CT with IV contrast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

If the patient complains of difficulty swallowing due to mediastinal mass, what test could be run?

A

Barium swallow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

If there is a suspected malignancy of mediastinal mass, what test should be run first?

A

PET scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

PET scan

A

Shows metabolic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Anti-acetylcholine receptor antibodies are elevated in ___ tumors

A

Thymic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Alpha fetoprotein and beta HCG are elevated in ___ tumors

A

Germ cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

LDH is elevated in ___ tumors

A

Seminomas and lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Referral for mediastinal masses

A

Cardiothoracic or general surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Indications for percutaneous biopsy of mediastinal mass

A

If it is near the periphery of the chest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Percutaneous biopsy

A

Uses CT guidance for exact location of biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Indications for endobronchial biopsy
If mediastinal mass is located immediately adjacent to an airway
26
Indications for mediastinoscopy biopsy
If they are also planning to resect the tumor at that time
27
Characteristics of a solitary pulmonary nodule (SPN)
Less than 3cm Isolated and round opacity Surrounded by normal lung Not associated with infiltrate, atelectasis, or adenopathy
28
T/F most SPN are malignant
F - most are benign
29
Benign causes of SPN
Infectious granulomas Hamartomas Pulmonary AV malformation
30
MC organisms that cause infectious granuloma SPN
Endemic fungi Mycobacteria
31
Appearance of infectious granuloma SPN
Well-demarcated, fully calcified, or centrally calcified
32
Presentation of hamartoma
Heterogenous CXR: popcorn CT: areas of fat
33
Pulmonary AV malformation
Tangle of connecting arteries and veins causing a hard time for blood to move through
34
Should you biopsy pulmonary AV malformations?
No - there is a bleeding risk
35
Malignant causes of an SPN
Primary lung cancer Lung metastasis Carcinoid tumors
36
Most pulmonary metastases present as ___
Multiple nodes
37
Risk factors for malignancy in SPN
Smoking Age Family History Female sex Emphysema Previous malignancy Asbestos exposure
38
You should repeat CXR prior to ordering CT if ___
Suspected nodule is likely a nipple shadow Evidence of infection Nodule characteristics are pathognomonic for benign lesion
39
Imaging modality of choice for SPN
CT chest w/o contrast
40
CT imaging helps to assess malignancy risk factors such as ___
Size Location Attenuation Calcification
41
___ nodules have a higher malignancy rate
Larger
42
Nodules found in the ___ have an increased risk of being malignant
Upper lobe
43
(Solid/subsolid) nodules are more likely to be malignant
Subsolid
44
Types of subsolid nodules
Ground glass nodules Part-solid nodules
45
Shape of nodules that are more likely to be malignant
Ill-defined, lobular, spiculated, and peripheral halo Benign lesions have smooth, well-defined borders
46
Growth of SPN
More likely to see growth on malignant tumors Benign tumors are likely stable
47
Calcification patterns of SPN
Benign: diffuse, central, popcorn, laminated Malignant: stippled and eccentric
48
If the nodule is over 3cm, then it is already classified as ___ risk
High
49
If the nodule is under 3cm, how do you determine risk?
Risk calculator
50
Risk calculator for determining malignancy probability
Low: less than 5% Intermediate: 5-60% High: over 60%
51
Management of low probability SPN
Watchful waiting with serial CT scans
52
Management of high probability SPN
Surgical resection and staging
53
Management for intermediate probability SPN
If a central lesion: sputum cytology If you suspect malignancy: PET scan Biopsy for further malignancy testing
54
Management of patients with multiple nodules
Each nodule should be assessed individually for the probability of malignancy
55
Bronchogenic carcinoma
Malignant tumors arising from the respiratory epithelium, which excludes the bronchi, bronchioles and alveoli (lung cancer)
56
T/F second hand smoke exposure is still a significant risk factor for the development of lung cancer
True
57
Median age of lung cancer diagnosis
70
58
Risk factors for lung cancer
Smoking Age Occupational exposure Family history COPD
59
Screening criteria for lung cancer
Must be between 50-80 In good health Currently smokers or has quit within the last 15 years Has a 20 pack year history
60
Modality of lung cancer screening
Annual low-dose CT
61
Clinical presentation of lung cancer
Intrathoracic symptoms: cough, sputum streaked with blood, chest pain, SOB, recurrent infections
62
Intrathoracic complications
Malignant pleural effusions Superior vena cava syndrome Pan coast tumor
63
How is malignant pleural effusion managed?
Palliatively
64
How to identify the presence of malignancy cells in the pleural fluid?
Cytology
65
Superior vena cava syndrome
Compression of the SVC by pulmonary mass leading to facial and neck edema
66
CXR of superior vena cava syndrome
Mediastinal widening or high hilar mass
67
Pancoast tumor
Tumor in the apex of the lung causing compression of surrounding structures
68
Symptoms of pancoast tumor
Shoulder pain Horners syndrome Bone destruction around the tumor
69
Initial imaging modality for lung cancer
CXR
70
Indications for chest CT for lung cancer
New or enlarging lesion Pleural effusion
71
What type of CT is used for lung cancer?
With contrast
72
T/F: the whole body PET scans are recommended for lung cancer
False - targeted PET scans are utilized for organs suspected of having malignancy based upon symptoms and CT imaging
73
PET false negatives
Diabetics Small lesions Slow-growing tumors
74
PET false positives
Certain infections and granulomatous disease
75
When are labs indicated for suspected lung cancer?
If radiologic evidence shows likely malignancy
76
MC sites for distant metastatic lung cancer
Liver Adrenal glands Bones Brain
77
Liver mets in lung cancer
Often asymptomatic Elevated LFTs
78
Imaging of choice for liver mets in lung cancer
CT w/o contrast
79
Bone mets in lung cancer
Pain in the back, chest, or extremities Elevated serum alk phos and serum Ca
80
Imaging of choice for bone mets in lung cancer
PET scan
81
Adrenal mets in lung cancer
Often asymptomatic and found incidentally on staging CT
82
Imaging of choice in adrenal mets in lung cancer
PET scan
83
Brain mets in lung cancer
N/V, vision changes, papilledema, cranial nerve deficit
84
Imaging modality for brain mets of lung cancer
MRI with contrast
85
Only definitive way to make the diagnosis of malignancy in lung cancer
Biopsy
86
Modality options for primary neoplasm of lung biopsy
Endobronchial ultrasound bronchoscopy: preferred for centrally located tumors Transthoracic percutaneous fine-needle aspiration with CT guidance: preferred for peripherally located tumors
87
Biopsy modalities for lung cancer
Video-assisted thoracic surgery Mediastinoscopy for tumors that are going to be resected anyways
88
Classification of WHO lung cancer
Small cell lung cancer Adenocarcinoma Squamous cell carcinoma Large cell carcinoma
89
Small cell carcinoma patient population
Almost always a smoker
90
Where does small cell carcinoma generally start?
Bronchi (centrally located)
91
How is small cell carcinoma usually detected?
Large hilar mass with bulky mediastinal adenopathy
92
Most common type of lung cancer
Non-small cell lung cancer
93
Most common form of lung cancer in nonsmokers
Adenocarcinoma
94
Adenocarcinoma
Slow-growing and usually involves the periphery of the lung
95
Squamous cell carcinoma generally occurs in the ___ and develops in ___
Large cell carcinomas
96
Large cell carcinomas
Rapidly-growing mass occurring anywhere in the lung
97
Location of large cell carcinoma
Peripheral
98
TNM staging
Tumor: size of tumor Node: lymph node involvement Metastasis: mets to other organs
99
Stage 1 NSCLC
No nodal involvement or mets
100
Treatment of stage 0 NSCLC (in situ)
Surgery alone is usually curative for these patients
101
Treatment of stage 1 NSCLC
Surgery Radiation if the surgical margins are positive and patient isn't a candidate for surgery
102
Treatment of stage 2 and 3 NSCLC
Surgical resection Followed by chemo Post-op radiation if positive surgical margins and is not a candidate for surgery
103
Stage 4 NSCLC
Wide-spread with distant mets
104
Treatment of stage 4 NSCLC
Chemotherapy Palliative radiation and surgery
105
Prognosis of NSCLC
5 year survival is 10-15%
106
Limited stage SCLC
Patients with no distant mets and no evidence of disease in the mediastinum Patients with clinical or pathologic evidence of mediastinal disease or mets
107
Treatment for limited stage SCLC in patients with no distant mets and evidence of disease in the mediastinum
Resection followed by chemo
108
Treatment for limited stage SCLC in patients with evidence of mediastinal disease or mets
Chemoradiotherapy as initial therapy
109
Extensive stage SCLC
Tumor extends beyond the hemithorax
110
Treatment of extensive stage SCLC
Systemic chemo
111
Prognosis of SCLC
Rarely survive more than a few months without treatment
112
Paraneoplastic syndrome
Release of hormones by a tumor that affects other organ systems
113
Hypercalcemia in paraneoplastic syndrome
Tumor secretion of parathyroid hormone related protein and calcitriol inciting osteoclastic activity
114
S/S of hypercalcemia in paraneoplastic syndrome
Anorexia N/V/C Polyuria Polydipsia Dehydration
115
Hypercalcemia is most often associated with ___ paraneoplastic syndrome
Advanced stage
116
SIADH paraneoplastic syndrome
Tumor releases ADH
117
SIADH paraneoplastic syndrome is most commonly associated with ___
SCLC
118
S/S of SIADH paraneoplastic syndrome
Hyponatremia (neuro changes) N/V Anorexia
119
Lung cancer is the most common cancer associated with paraneoplastic ___ syndromes
Neurologic
120
Neurologic presentations are most often associated with ___
SCLC
121
MC neurologic paraneoplastic syndrome
Lambert-Eaton myasthenic syndromes
122
Lambert-Eaton myasthenic syndrome
Autoantibody formation results in impaired release of ACH which leads to poor muscle contraction
123
Hypertrophic osteoarthropathy paraneoplastic syndrome
Symmetrical painful arthropathy that usually involves the ankles, knees, wrists, and elbows Digital clubbing Periosteal new bone formation
124
Dermatomyositis/polymyositis paraneoplastic syndrome
Inflammatory myopathies manifested by muscle weakness
125
Cushing syndrome paraneoplastic syndrome
Ectopic production of ACTH
126
Bronchial carcinoid tumor
Rare type of lung cancer that develops in the central bronchi and rarely metastasizes
127
Bronchial carcinoid tumor commonly presents before ___
60
128
T/F - there are links to bronchial carcinoid tumor and smoking
False
129
Clinical presentation of bronchial carcinoid tumor
Hemoptysis Cough Wheezing Recurrent pneumonia
130
Bronchoscopy of bronchial carcinoid tumor
Pink/purple tumor in the central airway
131
Why is the bronchial carcinoid tumor purple?
High vascularity
132
Management of bronchial carcinoid tumor
Observation with serial CT Surgically remove if symptomatic